Abstract
Context: Organoselenium compounds have been described as antioxidant and neuroprotective agents. Objective: To evaluate the antioxidant action of 2,2′-dithienyl diselenide (DTDS) and its effects in brain monoamine oxidase (MAO) activity in vitro. Materials and methods: Assays for reactive species (RS), lipid peroxidation, protein oxidation, MAO A and B activities in rat brain homogenate as well as mimetic dehydroascorbate reductase and glutathione S-transferase activities were performed using DTDS (μM range). Results: DTDS was effective in decreasing the levels of RS as well as lipid peroxidation induced by malonate, sodium nitroprusside or FeCl2/EDTA and protein carbonyl in the rat brain homogenate. DTDS elicited dehydroascorbate reductase-like and glutathione S-transferase-like activities. DTDS was effective in inhibiting both MAO-A and MAO-B activities. Discussion: The results demonstrated that DTDS is an antioxidant agent with non-selective inhibitory effect on MAO activity. Conclusion: DTDS is a promising molecule to be evaluated in experimental models of neurological diseases. © 2013 Informa UK, Ltd.
Cite
CITATION STYLE
Bortolatto, C. F., Chagas, P. M., Wilhelm, E. A., Zeni, G., & Nogueira, C. W. (2013). 2,2′-dithienyl diselenide, an organoselenium compound, elicits antioxidant action and inhibits monoamine oxidase activity in vitro. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(4), 677–684. https://doi.org/10.3109/14756366.2012.670805
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.